Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...

The major pharmaceutical companies remain dominant ... further facilitate the interaction between basic sciences and industry, and academic institutions are encouraged to spin off companies.

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

Divi’s Laboratories Limited specialises in producing active pharmaceutical ingredients and intermediates. The company is engaged in the manufacturing and custom synthesis of generic APIs and ...

Pharmaceutical sales are expected to grow 6.2% per year through 2028. Pharma stocks are good defensive investments. Some pay sizable dividends that can help offset the impact of inflation. The ...

Pharmaceutical companies have long argued ... Economic found the federal government spent a combined $11.7 billion on basic ...

Discover how the separation of structurally diverse pharmaceutical drug compounds can be achieved using a PRP-C18 column.

Oct. 01, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on developing treatments for gastrointestinal (GI) diseases, with a particular ...

COPENHAGEN, Denmark, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that it has commenced an underwritten public offering of $300,000,000 of American ...

Health experts, gathering at the U.N., have begun to shift their focus to try to provide access to basic drugs in countries ...

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides ...

Kairos Pharma, Ltd KAPA IPO will take place September, 12 on the NASDAQ exchange under the ticker KAPA. The company is offering shares at an expected price of $4.00 per share with an insider lock ...